Jeffrey was Chief Financial Officer at Atalanta Therapeutics, and Chief Financial Officer at Axial Therapeutics. Jeffrey Young joined Paratus Sciences in 2026.
Jeffrey Young is currently
Create your alert
to follow the career of Jeffrey Young.
Do you need to know more about Jeffrey Young? More results.
Report an error
Update the org chart details of Jeffrey Young.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.